NOV 13, 2015 01:29 PM PST

Scientists Created Killer Cells To Attack Cancer

WRITTEN BY: Kara Marker
Natural killer (NK) cells are lymphocytes normally found in the body that play a vital role in inducing cell death in abnormal cells like cancerous cells. Unfortunately, cancer often spreads too fast and too far for NK cells to prevent fatality. However, scientists from Cornell figured out a way to give these NK cells a boost, so cancer won't be able to stand a chance.

Referred to as "super natural killer cells," these specialized lymphocytes designed by Dr. Michael R. King and his team from Cornell are programmed to find and destroy cancer cells in the lymph nodes. Also known as stage II or III cancer, tumor cells "hang out" in lymph nodes in preparation for metastasis (stage IV cancer). Killing the cancer cells before they spread could greatly reduce the severity of disease surrounding continuous cancer development.
 
An NK cell attacking a cancer cell

The mechanism behind the super natural killer cells involves injecting liposomes armed with specialized receptors that attach to NK cells already in the lymph nodes. These specialized receptors, called "tumor necrosis factor related apoptosis-inducing ligand" (TRAIL), enhance the already-working, apoptosis-inducing, cancer-killing behavior of NK cells. Instead of letting the cancer slip away to metastasize, the cancer cell population is completely eliminated.

"We want to see lymph node metastasis become a thing of the past," said King. The paper resulting from his study was published in Biomaterials this month. 

With successful clinical trials completed in mice, this technology is one step closer to preventing cancer metastasis in humans. Diagnoses of cancer types like colorectal, breast, and lung cancers in the lymph nodes occur between 29 and 37 percent of the time. This technology could stop the cancer from moving any further than this and subsequently save a lot of lives.

Watch the following real time video of an NK cell destroying a cancerous cell.
 

 
Source: Cornell University
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 25, 2018
Immunology
SEP 25, 2018
A Better Place to Gain Weight
Weight gain among genders can have different outcomes....
OCT 10, 2018
Microbiology
OCT 10, 2018
It's Time for Your Annual Flu Shot
After last year's flu season killed around 80,000 people, the CDC is trying to get the word out about the flu vaccine....
OCT 14, 2018
Immunology
OCT 14, 2018
Malaria Vesicles Activating Immune Responses
Red blood cells infected with malaria will secrete small vesicles that activate pathogen receptors...
OCT 16, 2018
Drug Discovery
OCT 16, 2018
Immunotherapeutic Targets A Blood-Clotting Protein
Fibrin is a blood protein that normally does not cross to the brain, however, several neurological disorders have a defect in the blood-brain barrier that ...
NOV 13, 2018
Health & Medicine
NOV 13, 2018
Poop Preservation: A Call to Retain Microbial Diversity
The post-industrialized world may have increased our standard of living, but a new study suggests that it may have also adversely affected the microbes tha...
NOV 30, 2018
Immunology
NOV 30, 2018
Aspirin May Impove MS Symptoms
The medical benefits of aspirin have been known since ancient times. Hippocrates, c. 400 BC, prescribed the salicylate-rich bark and leaves of the willow t...
Loading Comments...